These ten large-cap stocks were the worst performers in the last week. Are they in your portfolio?
Summit Therapeutics (NASDAQ:SMMT) shares fell 14.37% last week after Citigroup downgraded the stock from Buy to Neutral but raised its price target from $19 to $23.
MakeMyTrip Limited (NASDAQ:MMYT) stock plummeted 12.46%.
Medpace Holdings, Inc. (NASDAQ:MEDP) stock fell 9.37% after Jefferies downgraded the stock from Buy to Hold and cut its price target from $415 to $345.
Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) stock lost 8.94% last week after Leerink Partners ...